Log in to search using one of your social media accounts:

 

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-674 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2018 Category: Research Source Type: funding

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-675 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use cancer health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. The long-term goal of this FOA is t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2018 Category: Research Source Type: funding

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional)
Funding Opportunity RFA-CA-18-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cance...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-17-020 from the NIH Guide for Grants and Contracts. Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomateria...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Type 1 diabetes (T1D) results in part from the autoimmune-mediated dysfunction or destruction of insulin-producing pancreatic beta cells. This funding opportunity is for projects that seek to discover ways to change the course of the disease by directly establishing tolerance. Immune responses could be engineered for tolerance induction through the manipulation of antigens, cells, or cellular microenvironments. Collaborations between T1D experts and investigators from other fields, including (but not limited to) cancer immunology and biomaterials engineering, are especially encouraged.Lisa Spain, Ph.D. | RFA-DK-17-020 (Sou...
Source: NIDDK Funding Opportunities - February 14, 2018 Category: Endocrinology Source Type: funding

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-655 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
Funding Opportunity PAR-18-654 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
Funding Opportunity PAR-18-639 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2018 Category: Research Source Type: funding

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
Funding Opportunity PAR-18-638 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2018 Category: Research Source Type: funding

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-641 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2018 Category: Research Source Type: funding

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-640 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2018 Category: Research Source Type: funding

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Funding Opportunity PA-18-629 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 5, 2018 Category: Research Source Type: funding

New York Breast, Cervical, and Colorectal Cancer Services Program
Funding to implement breast, cervical, and colorectal cancer screening and follow-up services programs in order to reduce morbidity, mortality, and health-related disparities among residents of New York state. Geographic coverage: New York -- New York State Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 2, 2018 Category: American Health Source Type: funding

Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-616 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity Announcement (FOA) is to support research projects using a Traceback approach to genetic testing to identify unaffected individuals at increased risk for cancer in different clinical contexts and communities, including racially/ethnically diverse populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2018 Category: Research Source Type: funding

Notice of Correction to Key Dates to PAR-18-361, "Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)"
Notice NOT-CA-18-052 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2018 Category: Research Source Type: funding

Notice of Pre-Application Webinar for PAR-18-583 "Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)"
Notice NOT-RM-18-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2018 Category: Research Source Type: funding

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-605 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-606 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding

NIH Announces Inclusion Across the Lifespan Policy
Last month, NIH announced a revision (NOT-OD-18-116) to a decades-old policy originally conceived in response to concerns that children were not appropriately included in clinical research. These changes broaden the policy to address inclusion of research participants of all ages, and as discussed at the last Advisory Committee to the NIH Director meeting, will apply beginning in 2019 to all NIH-supported research involving human subjects. Our goal is to ensure that the knowledge gained from NIH-funded research is applicable to all those affected by the conditions under study. To get here, NIH solicited feedback ...
Source: NIH Extramural Nexus - January 24, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Clinical Trials Source Type: funding

Notice of Expiration of PAR-16-249, "Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01)"
Notice NOT-CA-18-040 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2018 Category: Research Source Type: funding

Notice of Expiration for RFA-CA-17-022, "Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)"
Notice NOT-CA-18-051 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration for RFA-CA-17-021, "Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)"
Notice NOT-CA-18-050 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration for RFA-CA-17-020, "Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)"
Notice NOT-CA-18-049 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-16-212 "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01)"
Notice NOT-CA-18-044 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-16-213 "Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)"
Notice NOT-CA-18-045 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-17-124 "Perception and Cognition Research to Inform Cancer Image Interpretation (R21)"
Notice NOT-CA-18-042 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-17-125 "Perception and Cognition Research to Inform Cancer Image Interpretation (R01)"
Notice NOT-CA-18-043 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-15-309, "Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R21)"
Notice NOT-CA-18-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Notice of Expiration of PAR-15-308, "Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01)"
Notice NOT-CA-18-038 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2018 Category: Research Source Type: funding

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01, Clinical Trials Not Allowed)
Funding Opportunity PAR-18-583 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to use submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 16, 2018 Category: Research Source Type: funding

Notice of NIDCR's Participation in PAR-18-009 "Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)"
Notice NOT-DE-18-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2018 Category: Research Source Type: funding

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)
Funding Opportunity PAR-18-560 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials of relevance to the research mission of the National Cancer Institutes (NCI) Division of Cancer Treatment and Diagnosis (DCTD) programs. Applicants are strongly encouraged to consult the DCTD website, https://dctd.cancer.gov/, to learn more about the various program goals, research priorities and strategies developed to fight cancer. Applications submitted to this FOA must...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 5, 2018 Category: Research Source Type: funding

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Funding Opportunity PAR-18-559 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications that include investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and the NCI Division of Cancer Control and Population Sciences as based on their scientific missions. Applications for clinical trials submitted under this FOA should be hypothesis-driven, have clearly described aims and objectives, and have the potential to reduce the burden of cancer through improvements in k...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 5, 2018 Category: Research Source Type: funding

Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-552 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite U01 grant applications focused on advancing the understanding of mechanisms mediating aging in cancer. Qualifying applications must propose aging in cancer studies that are collaborations between non-NIH Principal Investigators (PIs) and intramural PIs from NCI and/or NIA as a co-investigator. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2017 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-531 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-532 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-529 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA)is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Given that the current emerging evidence from limited research indicates a potentially important role for early-life events and exposures in cancer development, it is necessary to better understand 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding

Free Continuing Education Credit Activity: Invasive Cancer Incidence, 2004 –2013, and Deaths, 2006–2015, in Nonmetropolitan and Metropolitan Counties of the United States
Medscape, LLC has partnered with CDC to provide online continuing medical education based on selected Morbidity and Mortality Weekly Report journal articles, specifically an activity that describes the U.S. incidence of and deaths from cancer during the last decade. Geographic coverage: Nationwide -- Centers for Disease Control and Prevention, Medscape, LLC (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 15, 2017 Category: American Health Source Type: funding

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl - Clinical Trial Not Allowed)
Funding Opportunity PA-18-496 from the NIH Guide for Grants and Contracts. This administrative supplement funding opportunity announcement is part of the Cancer Moonshot initiative to accelerate cancer research, and was developed in response to a recommendation from the Blue Ribbon Panel of experts charged with advising the National Cancer Advisory Board on the exceptional scientific opportunities that could be accelerated through this initiative. As part of the Cancer Moonshot initiative, the National Cancer Institute (NCI) created the Patient-Derived Xenograft (PDX) Development and Trial Centers Research Network (PDXNet...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 15, 2017 Category: Research Source Type: funding

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 and R21 Clinical Trial Optional)
Awards funding for innovative and promising intervention research designed to improve smoking cessation outcomes among socioeconomically disadvantaged populations. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 14, 2017 Category: American Health Source Type: funding

Surgical Disparities Research (R01 and R21 Clinical Trial Optional)
Grants to support investigative and collaborative research focused on understanding and addressing disparities in surgical care and outcomes in minority and health disparity populations. Geographic coverage: Nationwide -- Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Nursing Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Office of Research on Women ’s Health, U.S. Department of Health and Human Services (Sourc...
Source: Funding opportunities via the Rural Health Information Hub - December 12, 2017 Category: American Health Source Type: funding

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)
Funding Opportunity PA-18-493 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to understand how information technology (IT) can support systematic screening and treatment of depression in cancer patients in a variety of oncology practice settings. The goals of this FOA are to: identify new, IT-enabled delivery models that support systematic screening and treatment of depression in cancer patients; test the feasibility of implementing these new delivery models in a variety of oncology practice settings, especially those serving under-served populations; and test ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2017 Category: Research Source Type: funding

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)
Funding Opportunity PA-18-492 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to understand how information technology (IT) can support systematic screening and treatment of depression in cancer patients in a variety of oncology practice settings. The goals of this FOA are to: identify new, IT-enabled delivery models that support systematic screening and treatment of depression in cancer patients; test the feasibility of implementing these new delivery models in a variety of oncology practice settings, especially those serving under-served populations; and test ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2017 Category: Research Source Type: funding

Notice of Expiration of PAR-15-289 "The Pancreatic Cancer Detection Consortium (U01)"
Notice NOT-CA-18-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 8, 2017 Category: Research Source Type: funding

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)
Funding Opportunity PAR-18-466 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 6, 2017 Category: Research Source Type: funding

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-18-467 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 6, 2017 Category: Research Source Type: funding

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
Funding Opportunity PAR-18-476 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 5, 2017 Category: Research Source Type: funding

Cancer Research Education Grants Program - Courses for Skills Development (R25)
Funding Opportunity PAR-18-477 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged that propose innovative, state-of-the-art p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 5, 2017 Category: Research Source Type: funding

Cancer Research Education Grants Program - Research Experiences (R25)
Funding Opportunity PAR-18-478 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs tha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 5, 2017 Category: Research Source Type: funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)
Funding Opportunity RFA-CA-18-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications to incorporate a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program from currently funded NCI P50 specialized centers to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2017 Category: Research Source Type: funding